Clinical Trials › NCT05134441
Active, Not RecruitingPhase 3
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Sponsored by Immunic AG
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 1121
Target enrollment
4
U.S. states
Nov 2021
Start date
Sep 2033
Expected completion
Interventions / Treatments
IMU-838 tabletsPlacebo matching IMU-838 tablets
Conditions studied
Multiple Sclerosis
Where this trial is running (6 sites)
Florida3 sites
Bradenton · Naples · Ormond Beach
Arizona1 site
Phoenix
California1 site
West Hollywood
Illinois1 site
Northbrook
Participating MS centers on MS Buddy (3)
Regina Berkovich MD PhD Inc MS Neurology
West Hollywood, CA
West Hollywood, CA
Collier Neurologic Specialists
Naples, FL
Naples, FL
Neurology Associates of Ormond Beach
Ormond Beach, FL
Ormond Beach, FL
MS centers in Florida
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
